Acrivon Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline ALGT Q1 2026 Earnings EPS Beats Estimates by Over 12 as Allegiant Travel Outperforms OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Portfolio Performance KELYB Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment OCC Q1 2026 Earnings Narrowed Loss and Market Sentiment Boost Drive Stock Surge CRWS Q1 2026 Earnings Modest EPS of 014 Reported Stock Edges Higher